Skip to main content
SpringerLink
Log in

Mycoses in Neonates and Children

  • Chapter
  • First Online:
Clinical Practice of Medical Mycology in Asia

  • 429 Accesses

Abstract

Children at risk for invasive fungal infections (IFI) include neonates, critically sick children, children on cancer chemotherapy/stem cell transplant and those with primary or acquired immunodeficiency (Table 7.1). Like adults, the incidence of IFI in children is also increasing due to increase in the ‘at-risk group’. But limited trial data and non-availability of many paediatric antifungal formulations complicate treatment of IFI in children even more than adults. The burden and outcome of paediatric IFI in Asian countries are likely to be worse than resource-rich settings due to poor infection control practices in neonatal and paediatric intensive care units, overuse of antibiotics, increased mold spore counts in the hospital environment and residential dwellings, tropical climate, malnutrition, advanced disease at diagnosis, reduced awareness, lack of appropriate diagnostic facilities and cost/availability of antifungal drugs. This write-up gives a bird’s eye view of IFI in children from an Asian perspective. While knowledge and attention to guidelines is essential, what is more important is to formulate diagnostic and treatment algorithms based on local epidemiology, resources and availability.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Saiman L, Ludington E, P faller M, et al. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000;19:319.

    Article  CAS  Google Scholar 

  2. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birthweight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117:84–92.

    Article  Google Scholar 

  3. Basu S, Kumar R, Tilak R, Kumar A. Candida blood stream infection in neonates: experience from a Tertiary Care Teaching Hospital of Central India. Indian Pediatr. 2017;54(7):556–9.

    Article  Google Scholar 

  4. Jajoo M, Manchanda V, Chaurasia S, Sankar MJ, Gautam H, Agarwal R, et al. Investigators of the Delhi Neonatal Infection Study (DeNIS) Collaboration, New Delhi, India. Alarming rates of antimicrobial resistance and fungal sepsis in outborn neonates in North India. PLoS One. 2018;13(6):e0180705.

    Article  Google Scholar 

  5. Ariff S, Saleem AF, Soofi SB, Sajjad R. Clinical spectrum and outcomes of neonatal candidiasis in a tertiary care hospital in Karachi, Pakistan. J Infect Dev Ctries. 2011;5:216–23.

    Article  Google Scholar 

  6. Chakrabarti A, Singh K, Narang A, Singhi S, Batra R, Rao KL, et al. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India. J Clin Microbiol. 2001;39:1702–6.

    Article  CAS  Google Scholar 

  7. Patra S, Vij M, Chirla DK, Kumar N, Samal SC. Unsuspected invasive neonatal gastrointestinal mucormycosis: a clinicopathological study of six cases from a tertiary care hospital. J Indian Assoc Pediatr Surg. 2012;17:153–6.

    Article  Google Scholar 

  8. Kaur H, Ghosh A, Rudramurthy SM, Chakrabarti A. Gastrointestinal mucormycosis in apparently immunocompetent hosts—a review. Mycoses. 2018;61(12):898–908.

    Article  Google Scholar 

  9. Castagnola E, Buratti S. Clinical aspects of invasive candidiasis in paediatric patients. Drugs. 2009;69(Suppl 1):45–50.

    Article  Google Scholar 

  10. Manzoni P, Mostert M, Galletto P, et al. Is thrombocytopenia suggestive of organism-specific response in neonatal sepsis? Pediatr Int. 2009;51:206–10.

    Article  Google Scholar 

  11. Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):409–17.

    Article  Google Scholar 

  12. Kaufman DA. Challenging issues in neonatal candidiasis. Curr Med Res Opin. 2010;26:1769–78.

    Article  CAS  Google Scholar 

  13. Ericson JE, Kaufman DA, Kicklighter SD, Bhatia J, Testoni D, Gao J, et al. Fluconazole Prophylaxis Study Team on behalf of the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee; Fluconazole Prophylaxis Study Team on behalf of the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee. Fluconazole prophylaxis for the prevention of candidiasis in premature infants: a meta-analysis using patient-level data. Clin Infect Dis. 2016;63:604–10.

    Google Scholar 

  14. Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics. 1999;103(4):e39.

    Article  CAS  Google Scholar 

  15. Zaoutis TE, Prasad PA, Localio AR, Coffin SE, Bell LM, Walsh TJ, Gross R. Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention. Clin Infect Dis. 2010;51:e38–45.

    Article  Google Scholar 

  16. Singhi S, Rao DS, Chakrabarti A. Candida colonization and candidemia in a pediatric intensive care unit. Pediatr Crit Care Med. 2008;9:91–5.

    Article  Google Scholar 

  17. Chakrabarti A, Sood P, Rudramurthy SM, Chen S, Kaur H, Capoor M, et al. Incidence, characteristics and outcome of ICU-acquired candidemia in India. Intensive Care Med. 2015;41:285–95.

    Article  Google Scholar 

  18. Calitri C, Caviglia I, Cangemi G, Furfaro E, Bandettini R, Fioredda F, et al. Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children. Mycoses. 2017;60:789–95.

    Article  CAS  Google Scholar 

  19. Eggimann P, Bille J, Marchetti O. Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care. 2011;1(1):37.

    Article  Google Scholar 

  20. Kumar S, Bansal A, Chakrabarti A, Singhi S. Evaluation of efficacy of probiotics in prevention of candida colonization in a PICU—a randomized controlled trial. Crit Care Med. 2013;41:565–72.

    Article  Google Scholar 

  21. Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia in a pediatric patient after treatment with probiotics. Rev Paul Pediatr. 2017;35(3):361–4.

    Article  Google Scholar 

  22. Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. 2014;15:e327–40.

    Article  Google Scholar 

  23. Kumar J, Singh A, Seth R, Xess I, Jana M, Kabra SK. Prevalence and predictors of invasive fungal infections in children with persistent febrile neutropenia treated for acute leukemia—a prospective study. Indian J Pediatr. 2018;85:1090–5. https://doi.org/10.1007/s12098-018-2722-0.

    Article  PubMed  Google Scholar 

  24. Lin GL, Chang HH, Lu CY, Chen CM, Lu MY, Lee PI, et al. Clinical characteristics and outcome of invasive fungal infections in pediatric acute myeloid leukemia patients in a medical center in Taiwan. J Microbiol Immunol Infect. 2018;51:251–9.

    Article  Google Scholar 

  25. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813–21.

    Google Scholar 

  26. Dvorak CC, Fisher BT, Sung L, Steinbach WJ, Nieder M, Alexander S, Zaoutis TE. Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data. Pediatr Blood Cancer. 2012;59:21–6.

    Article  Google Scholar 

  27. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143–238.

    Article  CAS  Google Scholar 

  28. Mandhaniya S, Swaroop C, Thulkar S, Vishnubhatla S, Kabra SK, Xess I, Bakhshi S. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study. J Pediatr Hematol Oncol. 2011;33:e333–41.

    Article  CAS  Google Scholar 

  29. Antachopoulos C. Invasive fungal infections in congenital immunodeficiencies. Clin Microbiol Infect. 2010;16:1335–42.

    Article  CAS  Google Scholar 

  30. Siberry GK, Abzug MJ, Nachman S. Panel on Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Executive summary: 2013 update of the guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. Pediatr Infect Dis J. 2013;32:1303–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Kokilaben Dhirubhai Ambani Hospital and Medical Research Institute, Mumbai, India

    Tanu Singhal

  2. Department of Paediatrics, Kokilaben Hospital, Mumbai, India

    Tanu Singhal

Authors
  1. Tanu Singhal
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tanu Singhal .

Editor information

Editors and Affiliations

  1. Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India

    Arunaloke Chakrabarti

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Singhal, T. (2020). Mycoses in Neonates and Children. In: Chakrabarti, A. (eds) Clinical Practice of Medical Mycology in Asia. Springer, Singapore. https://doi.org/10.1007/978-981-13-9459-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-9459-1_7

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-9458-4

  • Online ISBN: 978-981-13-9459-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation